1832 Asset Management L.P. Tg Therapeutics, Inc. Transaction History
1832 Asset Management L.P.
- $48.7 Billion
- Q1 2025
A detailed history of 1832 Asset Management L.P. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, 1832 Asset Management L.P. holds 1,483,800 shares of TGTX stock, worth $58.3 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,483,800
Previous 1,655,100
10.35%
Holding current value
$58.3 Million
Previous $49.8 Million
17.44%
% of portfolio
0.12%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
416Shares Held
88.1MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$613 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$448 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$292 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$129 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$112 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.71B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...